2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Venous Thromboembolism
4
Venous Thrombosis
3
Neoplasms
3
Thromboembolism
2
Pulmonary Embolism
2
Ovarian Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Thrombosis
1
Sarcoma
1
Postoperative Complications
1
Lung Neoplasms
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
apixaban
6
Heparin, Low-Molecular-Weight
4
Enoxaparin
4
Dalteparin
4
Rivaroxaban
3
Blood Specimen Collection
3
Warfarin
2
Injections
2
Aspirin
2
Anticoagulants
2
salicylhydroxamic acid
1
palbociclib
1
fluorescein isothiocyanate-keyhole limpet hemocyanin
1
enoxaparin sodium
1
edoxaban
1
bemiparin
1
X-Rays
1
Ultrasonography
1
Tinzaparin
1
Technetium Tc 99m Sulfur Colloid
1
Standard of Care
1
Simvastatin
1
Saline Solution
1
Radiotherapy, Conformal
1
Physical Therapy Modalities
1
Photons
1
Phlebotomy
1
Paclitaxel
1
Observation
1
Musculoskeletal Manipulations
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thrombosis
×
Fondaparinux
×
Clear all
NCT02744092
2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA
Completed
811 enrolled
19 charts